Human Rabies Vaccine Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global human rabies vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The rabies vaccine is administered to prevent rabies. There are a number of such vaccines available found to be both safe and effective. They can be used to prevent rabies before, and for a period after exposure to the rabies virus, commonly caused by a dog bite or a bat bite. The major factors attributed to the market growth include the growing number of mortalities as a result of rabies coupled with the increasing number of unvaccinated stray dogs in less economically developed development countries. Apart from the stray dogs, the rising number of pets coupled with the poor pet management services and their low immunization rates are also estimated to spur the growth of the global human rabies vaccines market.
To Request a Sample of our Report on Human Rabies
Vaccine Market: https://www.omrglobal.com/request-sample/human-rabies-vaccine-market
As per the World Health Organization (WHO), around 99% of
rabies cases reported in 2015 were from domestic dogs. Other animals leading to
rabies infection can be wild dogs, bats, foxes, raccoons, cats, and skunks.
Contact with saliva, bites, and scratches by these animals are supposed to be
the major causes of rabies infection. Most of the rabies-related mortalities in
the US are caused by bats. Low economic and rural regions have high number of
rabies cases. Over 40% of patients suffering from rabies are children under 15
years of age.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
•
By Product Type
•
By Vaccination Type
Regions covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape: Zoetis Inc., Sanofi
S.A., and Merck & Co., Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Human Rabies Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/human-rabies-vaccine-market
Global Human Rabies Vaccine Market Report by Segment
By Product Type
• Vero Cell
• Baby
Hamster Kidney (BHK)
• Chick
Embryo Cell
• Human
Diploid Cells
• Others
By Vaccination Type
• Pre-Exposure
Vaccination (PEV)
• Post-Exposure
Prophylaxis (PEP)
Global Human Rabies Vaccine Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment